🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 122,22 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 148,73 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 2 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 02/03/1989 | 0,0652 USD |
| 29/11/1988 | 0,0588 USD |
| 29/08/1988 | 0,0469 USD |
| 03/06/1988 | 0,0509 USD |
| 29/02/1988 | 0,0509 USD |
| 01/12/1987 | 0,0424 USD |
| 28/08/1987 | 0,0424 USD |
| 02/06/1987 | 0,0292 USD |
| 02/03/1987 | 0,0292 USD |
| 02/12/1986 | 0,0292 USD |
| 02/09/1986 | 0,0292 USD |
| 03/06/1986 | 0,0239 USD |
| 27/02/1986 | 0,0239 USD |
| 03/12/1985 | 0,0239 USD |
| 30/08/1985 | 0,0212 USD |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 16/02/2017 | 62,16 | 62,41 | 61,51 | 62,27 | +0,15% | 1,46% | 12.938.922 |
| 15/02/2017 | 61,93 | 62,85 | 61,88 | 62,18 | -0,76% | 1,57% | 18.662.050 |
| 14/02/2017 | 61,68 | 62,71 | 61,48 | 62,65 | +1,37% | 2,00% | 10.629.550 |
| 13/02/2017 | 61,31 | 61,86 | 61,28 | 61,80 | +0,97% | 0,95% | 7.494.353 |
| 10/02/2017 | 61,37 | 61,61 | 61,03 | 61,21 | -0,37% | 0,95% | 8.940.907 |
| 09/02/2017 | 61,37 | 61,85 | 61,36 | 61,44 | +0,11% | 0,81% | 7.391.439 |
| 08/02/2017 | 60,97 | 61,53 | 60,91 | 61,37 | +0,19% | 1,02% | 6.190.326 |
| 07/02/2017 | 61,79 | 61,96 | 61,12 | 61,26 | -1,14% | 1,36% | 8.840.194 |
| 06/02/2017 | 60,99 | 61,98 | 60,97 | 61,97 | +1,01% | 1,64% | 9.598.422 |
| 03/02/2017 | 60,94 | 61,38 | 60,37 | 61,35 | +0,17% | 1,66% | 12.209.724 |
| 02/02/2017 | 59,77 | 61,27 | 59,67 | 61,24 | +3,35% | 2,68% | 19.901.730 |
| 01/02/2017 | 59,22 | 59,42 | 58,74 | 59,26 | +0,18% | 1,14% | 11.547.702 |
| 31/01/2017 | 58,26 | 59,39 | 58,13 | 59,15 | +0,91% | 2,16% | 10.292.513 |
| 30/01/2017 | 58,70 | 58,88 | 58,14 | 58,62 | -0,52% | 1,27% | 8.230.573 |
| 27/01/2017 | 58,57 | 59,15 | 58,49 | 58,92 | +0,90% | 1,12% | 6.972.554 |
| 26/01/2017 | 58,23 | 58,55 | 57,77 | 58,40 | +0,20% | 1,34% | 13.317.460 |
| 25/01/2017 | 58,51 | 58,57 | 57,98 | 58,28 | -0,21% | 1,01% | 15.255.736 |
| 24/01/2017 | 58,77 | 58,86 | 57,95 | 58,41 | -0,97% | 1,56% | 10.990.900 |
| 23/01/2017 | 58,98 | 59,54 | 58,81 | 58,98 | -1,15% | 1,25% | 10.691.382 |
| 20/01/2017 | 59,54 | 60,04 | 59,30 | 59,67 | +3,65% | 1,23% | 26.451.834 |
| 19/01/2017 | 58,25 | 58,28 | 57,32 | 57,57 | -1,37% | 1,65% | 11.944.999 |
| 18/01/2017 | 58,57 | 58,95 | 58,28 | 58,37 | -0,50% | 1,14% | 8.522.022 |
| 17/01/2017 | 59,08 | 59,23 | 58,40 | 58,66 | -1,38% | 1,41% | 11.101.150 |
| 13/01/2017 | 59,48 | 59,81 | 59,26 | 59,48 | +0,21% | 0,93% | 10.447.617 |
| 12/01/2017 | 59,67 | 60,34 | 59,27 | 59,36 | +0,94% | 1,79% | 26.079.899 |
| 11/01/2017 | 59,48 | 60,27 | 57,97 | 58,81 | +2,85% | 3,87% | 34.281.862 |
| 10/01/2017 | 58,40 | 58,44 | 57,15 | 57,18 | -1,93% | 2,21% | 16.036.706 |
| 09/01/2017 | 57,54 | 58,66 | 57,33 | 58,30 | +1,38% | 2,32% | 10.201.861 |
| 06/01/2017 | 57,34 | 57,69 | 56,80 | 57,51 | +0,27% | 1,55% | 10.730.053 |
| 05/01/2017 | 57,46 | 57,81 | 57,25 | 57,36 | -0,03% | 0,96% | 10.581.446 |